BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 26316478)

  • 1. Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).
    Boğa C; Bolaman Z; Çağırgan S; Karadoğan İ; Özcan MA; Özkalemkaş F; Saba R; Sönmez M; Şenol E; Akan H; Akova M
    Turk J Haematol; 2015 Jun; 32(2):100-17. PubMed ID: 26316478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Quasi-Experimental Study Analyzing the Effectiveness of Portable High-Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction.
    Özen M; Yılmaz G; Coşkun B; Topçuoğlu P; Öztürk B; Gündüz M; Atilla E; Arslan Ö; Özcan M; Demirer T; İlhan O; Konuk N; Balık İ; Gürman G; Akan H
    Turk J Haematol; 2016 Mar; 33(1):41-7. PubMed ID: 26376622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
    Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
    Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.
    Douglas AP; Slavin MA
    Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1165-1177. PubMed ID: 27710140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell'Adulto, Gruppo Italiano Trapianto di Midollo Osseo, Associazione Italiana Ematologia ed Oncologia Pediatrica, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Sorveglianza Epidemiologica delle Infezioni Fungine nelle Emopatie Maligne.
    Girmenia C; Aversa F; Busca A; Candoni A; Cesaro S; Luppi M; Pagano L; Rossi G; Venditti A; Nosari AM; ; ; ; ;
    Hematol Oncol; 2013 Sep; 31(3):117-26. PubMed ID: 23037867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials.
    Lee CH; Lin C; Ho CL; Lin JC
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Invasive fungal infection management in patients with hematological malignancies].
    Kanda Y
    Rinsho Ketsueki; 2022; 63(9):1270-1278. PubMed ID: 36198553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Ruhnke M; Cornely OA; Schmidt-Hieber M; Alakel N; Boell B; Buchheidt D; Christopeit M; Hasenkamp J; Heinz WJ; Hentrich M; Karthaus M; Koldehoff M; Maschmeyer G; Panse J; Penack O; Schleicher J; Teschner D; Ullmann AJ; Vehreschild M; von Lilienfeld-Toal M; Weissinger F; Schwartz S
    Mycoses; 2020 Jul; 63(7):653-682. PubMed ID: 32236989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
    Tacke D; Buchheidt D; Karthaus M; Krause SW; Maschmeyer G; Neumann S; Ostermann H; Penack O; Rieger C; Ruhnke M; Sandherr M; Schweer KE; Ullmann AJ; Cornely OA
    Ann Hematol; 2014 Sep; 93(9):1449-56. PubMed ID: 24951122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylaxis of fungal infections in haematological patients: pro].
    Glass B
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1870. PubMed ID: 20842607
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacist review of high-risk haematology outpatients to improve appropriateness of antifungal prophylaxis.
    Reslan Z; Lindsay J; Kerridge I; Gellatly R
    Int J Clin Pharm; 2020 Dec; 42(6):1412-1418. PubMed ID: 33009604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive aspergillosis in patients with hematologic malignancies.
    Wiederhold NP; Lewis RE; Kontoyiannis DP
    Pharmacotherapy; 2003 Dec; 23(12):1592-610. PubMed ID: 14695039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is preemptive antifungal therapy a good alternative to empirical treatment in prolonged febrile neutropenia?
    Koch E; Rada G
    Medwave; 2016 Jun; 16 Suppl 2():e6463. PubMed ID: 27280389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?
    Rogers TR; Slavin MA; Donnelly JP
    Br J Haematol; 2011 Jun; 153(6):681-97. PubMed ID: 21504422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014.
    Blyth CC; Gilroy NM; Guy SD; Chambers ST; Cheong EY; Gottlieb T; McGuinness SL; Thursky KA
    Intern Med J; 2014 Dec; 44(12b):1333-49. PubMed ID: 25482744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal Pneumonia in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation.
    Pergam SA
    Clin Chest Med; 2017 Jun; 38(2):279-294. PubMed ID: 28477639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications of invasive mycoses in organ transplant recipients.
    Samanta P; Singh N
    Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1195-1202. PubMed ID: 27690694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies.
    Gamaletsou MN; Walsh TJ; Sipsas NV
    Turk J Haematol; 2018 Mar; 35(1):1-11. PubMed ID: 29391334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.